C1ORF174 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.371400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.045400E-01
Normal-vs-Stage2
5.102000E-01
Normal-vs-Stage3
2.327400E-01
Normal-vs-Stage4
3.270600E-01
Stage1-vs-Stage2
6.046000E-01
Stage1-vs-Stage3
5.194400E-01
Stage1-vs-Stage4
1.054980E-01
Stage2-vs-Stage3
1.370050E-01
Stage2-vs-Stage4
3.053700E-02
Stage3-vs-Stage4
3.720300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.212200E-01
Normal-vs-AfricanAmerican
5.331600E-01
Normal-vs-Asian
7.176400E-01
Caucasian-vs-AfricanAmerican
8.997800E-01
Caucasian-vs-Asian
7.793600E-01
AfricanAmerican-vs-Asian
7.980400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.464600E-01
Normal-vs-Female
5.492600E-01
Male-vs-Female
3.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.987200E-01
Normal-vs-Age(41-60Yrs)
6.116000E-01
Normal-vs-Age(61-80Yrs)
3.694400E-01
Normal-vs-Age(81-100Yrs)
6.141400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.746400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.223600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.111400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.061700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.451800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.821800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.829400E-01
Normal-vs-Daily Drinker
5.005000E-01
Normal-vs-Weekly Drinker
7.162600E-01
Normal-vs-Occasional Drinker
4.122400E-01
Normal-vs-Social Drinker
4.797800E-01
Non Drinker-vs-Daily Drinker
3.834200E-01
Non Drinker-vs-Weekly Drinker
2.197800E-01
Non Drinker-vs-Occasional Drinker
3.525800E-01
Non Drinker-vs-Social Drinker
1.265990E-01
Daily Drinker-vs-Weekly Drinker
6.342400E-01
Daily Drinker-vs-Occasional Drinker
9.697800E-01
Daily Drinker-vs-Social Drinker
6.299800E-01
Weekly Drinker-vs-Occasional Drinker
6.305200E-01
Weekly Drinker-vs-Social Drinker
8.997600E-01
Occasional Drinker-vs-Social Drinker
6.333000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.069800E-01
Normal-vs-Grade 2
9.505600E-01
Normal-vs-Grade 3
9.473200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.518100E-03
Grade 1-vs-Grade 3
6.235300E-03
Grade 1-vs-Grade 4
9.069800E-01
Grade 2-vs-Grade 3
9.238800E-01
Grade 2-vs-Grade 4
9.505600E-01
Grade 3-vs-Grade 4
9.473200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.337200E-01
Normal-vs-NonDiabetic
4.113200E-01
Diabetic-vs-NonDiabetic
3.293600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.210200E-01
Normal-vs-NoPancreatitis
3.597800E-01
Pancreatitis-vs-NoPancreatitis
5.052000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.227600E-01
Normal-vs-N1
5.641000E-01
N0-vs-N1
6.665800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.313200E-01
Normal-vs-TP53-NonMutant
2.652800E-01
TP53-Mutant-vs-TP53-NonMutant
4.626700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
